BPC 157: The Real Reason Why It's Not FDA Approved Stracuzzi Wellness FDA takes first step in possible reversal of ban on some peptides The Washington Post The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York